Finance

Lists
2197:HKG
Clover Biopharmaceuticals Ltd
1,54 HKD
+0,65%
(+0,0100) 1D
16-окт., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2197...
Open
1,60 HKD
High
1,60 HKD
Low
1,52 HKD
Mkt. cap
1,94 млд
Avg. vol.
2,99 млн
Volume
3,18 млн
P/E ratio
2,00
52-wk high
3,20 HKD
52-wk low
1,32 HKD
EPS
0,77 HKD
Shares outstanding
1,30 млд
No. of employees
257
Open
1,60 HKD
High
1,60 HKD
Low
1,52 HKD
Mkt. cap
1,94 млд
Avg. vol.
2,99 млн
Volume
3,18 млн
P/E ratio
2,00
52-wk high
3,20 HKD
52-wk low
1,32 HKD
EPS
0,77 HKD
Shares outstanding
1,30 млд
No. of employees
257
News stories
From web sources and news partners
About Clover Biopharmaceuticals Ltd
CEO-
Employees257
Founded2007
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
125,50 миң
125,50 миң
89,50 миң
89,50 миң
Cost of goods sold
119,00 миң
119,00 миң
2,86 млн
2,86 млн
Cost of revenue
119,00 миң
119,00 миң
2,86 млн
2,86 млн
Research and development expenses
49,54 млн
49,54 млн
52,42 млн
52,42 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,65 млн
18,65 млн
15,92 млн
15,92 млн
Operating expense
70,38 млн
70,38 млн
75,60 млн
75,60 млн
Total operating expenses
70,50 млн
70,50 млн
78,46 млн
78,46 млн
Operating income
-70,38 млн
-70,38 млн
-78,37 млн
-78,37 млн
Other non operating income
11,57 млн
11,57 млн
2,05 млн
2,05 млн
EBT including unusual items
-51,91 млн
-51,91 млн
477,49 млн
477,49 млн
EBT excluding unusual items
-51,71 млн
-51,71 млн
-66,01 млн
-66,01 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2,19 млн
2,19 млн
7,26 млн
7,26 млн
Net income
-51,91 млн
-51,91 млн
477,49 млн
477,49 млн
Net profit margin
-41 363,35%
-41 363,35%
533 506,15%
533 506,15%
Earnings per share
-
-
-
-
Interest and investment income
925,50 миң
925,50 миң
425,00 миң
425,00 миң
Interest expense
-64,50 миң
-64,50 миң
-34,50 миң
-34,50 миң
Net interest expenses
861,00 миң
861,00 миң
390,50 миң
390,50 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-66,72 млн
-66,72 млн
-74,11 млн
-74,11 млн
Gain or loss from assets sale
-2,00 миң
-2,00 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору